CN105440055B - 一种原研制品质头孢呋辛酸及其药物制剂 - Google Patents
一种原研制品质头孢呋辛酸及其药物制剂 Download PDFInfo
- Publication number
- CN105440055B CN105440055B CN201511032909.6A CN201511032909A CN105440055B CN 105440055 B CN105440055 B CN 105440055B CN 201511032909 A CN201511032909 A CN 201511032909A CN 105440055 B CN105440055 B CN 105440055B
- Authority
- CN
- China
- Prior art keywords
- cefuroxime
- reaction
- cefuroxime acid
- dichloromethane
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
- C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
- A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/02—Preparation
- C07D501/04—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
- C07D501/06—Acylation of 7-aminocephalosporanic acid
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Cephalosporin Compounds (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201511032909.6A CN105440055B (zh) | 2015-12-30 | 2015-12-30 | 一种原研制品质头孢呋辛酸及其药物制剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201511032909.6A CN105440055B (zh) | 2015-12-30 | 2015-12-30 | 一种原研制品质头孢呋辛酸及其药物制剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105440055A CN105440055A (zh) | 2016-03-30 |
CN105440055B true CN105440055B (zh) | 2017-11-07 |
Family
ID=55550746
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201511032909.6A Active CN105440055B (zh) | 2015-12-30 | 2015-12-30 | 一种原研制品质头孢呋辛酸及其药物制剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105440055B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112480146B (zh) * | 2020-10-30 | 2022-02-22 | 浙江惠迪森药业有限公司 | 一种头孢呋辛酸混合溶剂化物、晶型及制备方法 |
CN112745337B (zh) * | 2021-01-22 | 2022-07-29 | 华北制药河北华民药业有限责任公司 | 一种头孢呋辛酸的制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101613359A (zh) * | 2009-08-07 | 2009-12-30 | 哈药集团制药总厂 | 头孢呋辛钠合成方法 |
CN101974021A (zh) * | 2010-11-12 | 2011-02-16 | 山东建筑大学 | 一种头孢呋辛酸的合成方法 |
CN102652750A (zh) * | 2011-03-04 | 2012-09-05 | 珠海联邦制药股份有限公司 | 一种含头孢呋辛的药物组合物及其制剂和制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040092735A1 (en) * | 2002-11-08 | 2004-05-13 | Orchid Chemicals & Pharmaceuticals Limited | Process for the preparation of cefuroxime sodium |
WO2004050663A2 (en) * | 2002-12-05 | 2004-06-17 | Orchid Chemicals & Pharmaceuticals Ltd | An improved process for the preparation of cefuroxime sodium |
-
2015
- 2015-12-30 CN CN201511032909.6A patent/CN105440055B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101613359A (zh) * | 2009-08-07 | 2009-12-30 | 哈药集团制药总厂 | 头孢呋辛钠合成方法 |
CN101974021A (zh) * | 2010-11-12 | 2011-02-16 | 山东建筑大学 | 一种头孢呋辛酸的合成方法 |
CN102652750A (zh) * | 2011-03-04 | 2012-09-05 | 珠海联邦制药股份有限公司 | 一种含头孢呋辛的药物组合物及其制剂和制备方法 |
Non-Patent Citations (2)
Title |
---|
(6R,7R)-7-[2-呋喃基(甲氧亚氨基)乙酰氨基]-3-羟甲基8-氧代-5-硫杂-1-氮杂二环[4.2.0]辛-2-烯-2-甲酸的合成研究;赵卫良 等;《齐鲁药事》;20051231;第24卷(第4期);第365-366页 * |
新型磷酰活性酯法合成头孢呋辛酸的研究;任会学 等;《山东大学学报(理学版)》;20110331;第46卷(第3期);第9-12,17页 * |
Also Published As
Publication number | Publication date |
---|---|
CN105440055A (zh) | 2016-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105131017B (zh) | 一种盐酸头孢卡品酯的制备方法 | |
CN105399754B (zh) | 一种头孢孟多酯钠的制备方法 | |
CN105440055B (zh) | 一种原研制品质头孢呋辛酸及其药物制剂 | |
CN102030762A (zh) | 一种头孢丙烯的制备方法 | |
CN103435632A (zh) | 一种头孢呋辛酯的制备方法 | |
CN104193765B (zh) | 一种头孢克肟的合成方法 | |
CN103467496A (zh) | 7-[(噻唑基羟基亚氨基)乙酰氨基]-3-甲基头孢烷酸的制备方法及另一用途 | |
CN103319503A (zh) | 一种头孢地尼的制备方法 | |
CN109485658A (zh) | 一种头孢替唑酸的制备方法 | |
CN110407857B (zh) | 一种头孢硫脒的制备工艺 | |
CN104277053B (zh) | 一种头孢地嗪及其中间体头孢地嗪酸的制备方法 | |
SU847922A3 (ru) | Способ получени - - -( -окси- -метил-НиКОТиНАМидО)- -( -ОКСифЕНил)АцЕТАМидО - -( -МЕТилТЕТРАзОл- -ил)ТиОМЕТил- -цЕфЕМ- -КАРбОНОВОй КиСлОТы | |
CN105859747B (zh) | 一种适于工业化生产的盐酸头孢吡肟的制备方法 | |
CN101550146A (zh) | 一种盐酸头孢他美酯化合物及其制法 | |
CN103833772B (zh) | 一种头孢菌素的合成方法 | |
CN110669072A (zh) | 磷酸特地唑胺的精制方法 | |
CN102633814A (zh) | 头孢丙烯的制备方法 | |
CN108299469B (zh) | 一种头孢替安盐酸盐的制备方法 | |
CN107216353B (zh) | 一种头孢洛林酯咪唑盐的精制方法 | |
CN105254650A (zh) | 抗菌药物头孢西丁酸的合成方法 | |
CN111233894B (zh) | 一种头孢妥仑匹酯δ3异构体的制备方法 | |
CN103980293B (zh) | 3-乙烯基-7-(噻唑甲氧亚氨基)头孢烷酸的制备方法 | |
CN102898443A (zh) | 高收率超净高纯化头孢地嗪钠的精制方法 | |
CN102838621B (zh) | (6R,7R)-3-甲基-7-[α-(N,N’-二异丙基脒硫基)-乙酰氨基]-8-氧代-5-硫杂-1-氮杂双环[4,2,0]-辛-2-烯-2-甲酸内铵盐晶体 | |
CN111018889B (zh) | 一种头孢硫脒的合成方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 528415 Hongshan Road, Xiaolan Town, Guangdong, Zhongshan, China, No. 63 Applicant after: GUANGDONG JINCHENG JINSU PHARMACY Co.,Ltd. Applicant after: SHANDONG JINCHENG PHARMACEUTICAL & CHEMICAL Co.,Ltd. Address before: 528415 Hongshan Road, Xiaolan Town, Guangdong, Zhongshan, China, No. 63 Applicant before: ZHONGSHAN JINCHENG DOBFAR PHARMACEUTICAL CO.,LTD. Applicant before: SHANDONG JINCHENG PHARMACEUTICAL & CHEMICAL Co.,Ltd. |
|
COR | Change of bibliographic data | ||
CB02 | Change of applicant information |
Address after: 528415 Hongshan Road, Xiaolan Town, Guangdong, Zhongshan, China, No. 63 Applicant after: GUANGDONG JINCHENG JINSU PHARMACY Co.,Ltd. Applicant after: SHANDONG JINCHENG PHARMACEUTICAL GROUP CO.,LTD. Address before: 528415 Hongshan Road, Xiaolan Town, Guangdong, Zhongshan, China, No. 63 Applicant before: GUANGDONG JINCHENG JINSU PHARMACY Co.,Ltd. Applicant before: SHANDONG JINCHENG PHARMACEUTICAL CO.,LTD. Address after: 528415 Hongshan Road, Xiaolan Town, Guangdong, Zhongshan, China, No. 63 Applicant after: GUANGDONG JINCHENG JINSU PHARMACY Co.,Ltd. Applicant after: SHANDONG JINCHENG PHARMACEUTICAL CO.,LTD. Address before: 528415 Hongshan Road, Xiaolan Town, Guangdong, Zhongshan, China, No. 63 Applicant before: GUANGDONG JINCHENG JINSU PHARMACY Co.,Ltd. Applicant before: SHANDONG JINCHENG PHARMACEUTICAL & CHEMICAL Co.,Ltd. |
|
CB02 | Change of applicant information | ||
GR01 | Patent grant | ||
GR01 | Patent grant |